A new artificial intelligence (AI) model has just achieved human-level results on a test designed to measure “general intelligence.”
On December 20, OpenAI’s o3 system scored 85% on the ARC-AGI benchmark, well above the previous AI best score of 55% and on par with the average human score. It also scored well on a very difficult mathematics test.
Creating artificial general intelligence, or AGI, is the stated goal of all the major AI research labs. At first glance, OpenAI appears to have at least made a significant step towards this goal.
While skepticism remains, many AI researchers and developers feel something just changed. For many, the prospect of AGI now seems more real, urgent and closer than anticipated. Are they right?
Generalization and intelligence
To understand what the o3 result means, you need to understand what the ARC-AGI test is all about. In technical terms, it’s a test of an AI system’s “sample efficiency” in adapting to something new—how many examples of a novel situation the system needs to see to figure out how it works.
An AI system like ChatGPT (GPT-4) is not very sample efficient. It was “trained” on millions of examples of human text, constructing probabilistic “rules” about which combinations of words are most likely.
The result is pretty good at common tasks. It is bad at uncommon tasks, because it has less data (fewer samples) about those tasks.
Until AI systems can learn from small numbers of examples and adapt with more sample efficiency, they will only be used for very repetitive jobs and ones where the occasional failure is tolerable.
The ability to accurately solve previously unknown or novel problems from limited samples of data is known as the capacity to generalize. It is widely considered a necessary, even fundamental, element of intelligence.
Grids and patterns
The ARC-AGI benchmark tests for sample efficient adaptation using little grid square problems like the one below. The AI needs to figure out the pattern that turns the grid on the left into the grid on the right.

Each question gives three examples to learn from. The AI system then needs to figure out the rules that “generalize” from the three examples to the fourth.
These are a lot like the IQ tests sometimes you might remember from school.
Weak rules and adaptation
We don’t know exactly how OpenAI has done it, but the results suggest the o3 model is highly adaptable. From just a few examples, it finds rules that can be generalized.
To figure out a pattern, we shouldn’t make any unnecessary assumptions, or be more specific than we really have to be. In theory, if you can identify the “weakest” rules that do what you want, then you have maximized your ability to adapt to new situations.
What do we mean by the weakest rules? The technical definition is complicated, but weaker rules are usually ones that can be described in simpler statements.
In the example above, a plain English expression of the rule might be something like: “Any shape with a protruding line will move to the end of that line and ‘cover up’ any other shapes it overlaps with.”
Searching chains of thought?
While we don’t know how OpenAI achieved this result just yet, it seems unlikely they deliberately optimized the o3 system to find weak rules. However, to succeed at the ARC-AGI tasks, it must be finding them.
We do know that OpenAI started with a general-purpose version of the o3 model (which differs from most other models, because it can spend more time “thinking” about difficult questions) and then trained it specifically for the ARC-AGI test.
French AI researcher Francois Chollet, who designed the benchmark, believes o3 searches through different “chains of thought” describing steps to solve the task. It would then choose the “best” according to some loosely defined rule, or “heuristic.”
This would be “not dissimilar” to how Google’s AlphaGo system searched through different possible sequences of moves to beat the world Go champion.
You can think of these chains of thought like programs that fit the examples. Of course, if it is like the Go-playing AI, then it needs a heuristic, or loose rule, to decide which program is best.
There could be thousands of different seemingly equally valid programs generated. That heuristic could be “choose the weakest” or “choose the simplest.”
However, if it is like AlphaGo then they simply had an AI create a heuristic. This was the process for AlphaGo. Google trained a model to rate different sequences of moves as better or worse than others.
What we still don’t know
The question then is, is this really closer to AGI? If that is how o3 works, then the underlying model might not be much better than previous models.
The concepts the model learns from language might not be any more suitable for generalization than before. Instead, we may just be seeing a more generalizable “chain of thought” found through the extra steps of training a heuristic specialized to this test. The proof, as always, will be in the pudding.
Almost everything about o3 remains unknown. OpenAI has limited disclosure to a few media presentations and early testing to a handful of researchers, laboratories and AI safety institutions.
Truly understanding the potential of o3 will require extensive work, including evaluations, an understanding of the distribution of its capacities, how often it fails and how often it succeeds.
When o3 is finally released, we’ll have a much better idea of whether it is approximately as adaptable as an average human.
If so, it could have a huge, revolutionary, economic impact, ushering in a new era of self-improving accelerated intelligence. We will require new benchmarks for AGI itself and serious consideration of how it ought to be governed.
If not, then this will still be an impressive result. However, everyday life will remain much the same.
News
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
Two Hidden Forces Help Build the Human Brain Before Birth
Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known [...]
Researchers Uncover a Hidden Trigger Behind Chronic Inflammation
The findings offer new insights that could help guide the development of future therapies. A protein called human resistin may help flip on one of the immune system’s most powerful inflammatory switches. Researchers at [...]
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]















